Amdekar et al., 2010 - Google Patents

Probiotics: multifarious oral vaccine against infectious traumas

Amdekar et al., 2010

View HTML
Document ID
18104124822617485821
Author
Amdekar S
Dwivedi D
Roy P
Kushwah S
Singh V
Publication year
Publication venue
FEMS Immunology & Medical Microbiology

External Links

Snippet

Microorganisms have been used for a long time in food and alcoholic fermentation. In the last few years they have undergone scientific scrutiny of their preventative and therapeutic aspects. This has led to the discovery of a new term, probiotics. Lactic acid bacteria (LAB) …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0291—Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Similar Documents

Publication Publication Date Title
Amdekar et al. Probiotics: multifarious oral vaccine against infectious traumas
Szatraj et al. Lactic acid bacteria—promising vaccine vectors: possibilities, limitations, doubts
Wells et al. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Servin Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
Doron et al. Probiotics: their role in the treatment and prevention of disease
Kemgang et al. Cross‐talk between probiotic lactobacilli and host immune system
Cano-Garrido et al. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
Clark-Curtiss et al. Salmonella vaccines: conduits for protective antigens
Seegers Lactobacilli as live vaccine delivery vectors: progress and prospects
ES2290008T3 (en) USE OF LACTOBACILLUS SALIVARIUS.
Tanabe The effect of probiotics and gut microbiota on Th17 cells
Corthésy et al. Cross-talk between probiotic bacteria and the host immune system1
Perdigón et al. Lactic acid bacteria and their effect on the immune system
Lu et al. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium
JP4415164B2 (en) Probiotic Lactobacillus salivarius strain
Sanz et al. Probiotics as drugs against human gastrointestinal infections
Robinson et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C
Tsai et al. Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice
Mohamadzadeh et al. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria
Hanniffy et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health
Amalaradjou et al. Bioengineered probiotics, a strategic approach to control enteric infections
Abkar et al. Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection
Tavares et al. Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of Lactococcus lactis: the lactic acid bacterium model
Bahey-El-Din et al. Lactococcus lactis as a cell factory for delivery of therapeutic proteins
Wen et al. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli